Mindestbestellung 120 EUR Kostenlose Lieferung ab 250 EUR Bereit zur Abholung dead drop: in 5 Min. abholen Kostenloser Versand ab 250 EUR Aktionen

Substanzen · Benzodiazepine und Thienodiazepine

Norflurazepam

C15H10ClFN2O CAS 2886-65-9 Nur für analytische Forschungszwecke — nicht für den menschlichen Verzehr
Bevorzugter Name
Norflurazepam
IUPAC-Name
7-chloro-5-(2-fluorophenyl)-1,3-dihydro-1,4-benzodiazepin-2-one
CAS-Nummer der Stammverbindung (Referenz)
2886-65-9
Summenformel
C15H10ClFN2O
Molekulargewicht
288.7 g/mol
InChIKey
UVCOILFBWYKHHB-UHFFFAOYSA-N
PubChem
CID 4540
Quelle
PubChem
Geprüfte Synonyme und Katalogkürzel
N-Desalkylflurazepam Ro 5-3367

Passende Artikel im aktuellen Shop-Katalog

Geprüftes Pharmakologie- & Toxikologie-Dossier

Norflurazepam

Long-Acting Myorelaxant & Anxiolytic GABA-A PAM 1,4-Benzodiazepine
Geprüfte PubChem- & CAS-Identität C15H10ClFN2O · CAS 2886-65-9 · CID 4540
Kalibrierte Lieferform Präzisionstabletten · 1 Tablette = 1 mg
≥98 % analytische Reinheit geprüft 288.7 g/mol
WHO-, PubMed- & PubChem-Quellen 2 cited records

Rezeptor-Telemetrie & Wirkmechanismus

GABAₐ α₂/α₃ Anxiolysis & Myorelaxation High PAM
GABAₐ α₁ Hypnotic / Sedative Drive Very High
GABAₐ α₅ Amnestic / Cognitive Modulation High

N-Desalkylflurazepam, the principal long-lived active metabolite of flurazepam, binding broadly across synaptic GABA-A benzodiazepine sites.

Biotransformation & Active Metabolites

Glucuronidated slowly with a documented human elimination half-life of ~40–100 hours.

Zeitliche Pharmakokinetik

Long-Acting Myorelaxant & Anxiolytic GABA-A PAM — Gentle per-tablet scale (1 tablet = 1 mg; common literature range 5–10 mg) with warm myorelaxation and a smooth multi-day tail comparable to diazepam/diclazepam.

  1. Onset 30–90 min
  2. Peak Window 2–4 h
  3. Total Window 10–18 h
  4. Residual / Half-Life 24–60 h residual (T1/2 40–100 h)

Gentle per-tablet scale (1 tablet = 1 mg; common literature range 5–10 mg) with warm myorelaxation and a smooth multi-day tail comparable to diazepam/diclazepam.

Quantitatives Wirkungsspektrum (Literaturdaten)

Third-person observational & toxicological brackets reported in scientific and harm-reduction literature — reference telemetry only, never consumption advice.

Threshold
2 mg
Cognitive & Sensory

Subtle threshold receptor activity (Long-Acting Myorelaxant & Anxiolytic GABA-A PAM).

Somatic & Autonomic

Minimal baseline autonomic shift.

Light
2–5 mg
Cognitive & Sensory

Mild, clear-headed expression of primary class profile.

Somatic & Autonomic

Light somatic modulation.

Common Reference
5–10 mg
Cognitive & Sensory

Full characteristic neurochemical and perceptual profile documented in literature.

Somatic & Autonomic

Moderate somatic relaxation, ataxia, or autonomic tone depending on class.

Strong
10–15 mg
Cognitive & Sensory

Pronounced intensity, cognitive/motor impairment, or deep immersion.

Somatic & Autonomic

Marked somatic load and heightened adverse-event sensitivity.

Heavy / Toxic Zone
20+ mg
Cognitive & Sensory

Amnesia, blackout, acute dysphoria, confusion, or anesthetic dissociation.

Somatic & Autonomic

High toxicity zone: severe motor loss, cardiovascular strain, or respiratory hazard.

Wechselwirkungsmatrix — Niemals kombinieren

Lebensgefahr — Niemals kombinieren

Opioids (O-DSMT, tramadol, morphine, oxycodone, fentanyl)

Synergistic brainstem respiratory depression causing unconsciousness and fatal respiratory arrest.

Alcohol, GHB/GBL, and Barbiturates

Extreme CNS depression, complete anterograde amnesia, loss of airway reflexes, and fatal aspiration.

Hohes Risiko — Vermeiden

Dissociatives (Ketamine, 2-FDCK, DCK, O-PCE, MXE)

Unpredictable sedation, severe motor ataxia, blackout, and emesis aspiration hazard.

Vorsicht / Abschwächung

CYP3A4 inhibitors (grapefruit juice, ketoconazole) & Stimulants

CYP3A4 inhibitors prolong plasma half-life; stimulants mask sedation until they wear off.

Isomeren- & Strukturvergleich

Gentle per-tablet scale (1 tablet = 1 mg; common literature range 5–10 mg) with warm myorelaxation and a smooth multi-day tail comparable to diazepam/diclazepam.

Stabilität & Lagerung

Form: Precision-pressed 1 mg analytical tablets (1 tablet = 1 mg). · Parent molecule soluble in ethanol, propylene glycol, and DMSO; sparingly soluble in water.

Store sealed in a cool, dry, light-protected container away from humidity.

Cross-Tolerance & Dependence Profile

Complete cross-tolerance across all GABA-A benzodiazepines/thienodiazepines. Rapid physical dependence develops with continuous daily exposure; abrupt cessation after prolonged intake can trigger life-threatening rebound seizures and delirium.

Analytische & toxikologische Monographie

Norflurazepam (7-chloro-5-(2-fluorophenyl)-1,3-dihydro-1,4-benzodiazepin-2-one; CAS 2886-65-9, PubChem CID 4540) is a 1,4-benzodiazepine reference compound (C15H10ClFN2O, 288.7 g/mol) classified pharmacologically as a Long-Acting Myorelaxant & Anxiolytic GABA-A PAM. N-Desalkylflurazepam, the principal long-lived active metabolite of flurazepam, binding broadly across synaptic GABA-A benzodiazepine sites. Glucuronidated slowly with a documented human elimination half-life of ~40–100 hours. In published observational and toxicological literature, threshold response is noted at 2 mg, light range at 2–5 mg, common reference range at 5–10 mg, strong intensity at 10–15 mg, and heavy/adverse territory at 20+ mg, with an onset of 30–90 min, peak window of 2–4 h, and total duration of 10–18 h (24–60 h residual (T1/2 40–100 h)). Gentle per-tablet scale (1 tablet = 1 mg; common literature range 5–10 mg) with warm myorelaxation and a smooth multi-day tail comparable to diazepam/diclazepam. Critical contraindications include Opioids (O-DSMT, tramadol, morphine, oxycodone, fentanyl), Alcohol, GHB/GBL, and Barbiturates.

Chemische Struktur und Molekülprofil

Norflurazepam (7-chloro-5-(2-fluorophenyl)-1,3-dihydro-1,4-benzodiazepin-2-one) ist eine Referenzverbindung aus der Stoffklasse Benzodiazepine und Thienodiazepine mit der Summenformel C15H10ClFN2O und einer molaren Masse von 288.7 g/mol. Die Stammverbindung wird unter der CAS-Nummer 2886-65-9 sowie in der NCBI-PubChem-Datenbank unter CID 4540 geführt (Standard-InChIKey: UVCOILFBWYKHHB-UHFFFAOYSA-N).

Quellen

Referenztoxikologie und Sicherheitsprofil

Laut dokumentierten Referenzdaten (PubChem / PsychonautWiki, CC BY 4.0) gehört Norflurazepam zur chemischen Klasse Benzodiazepine und Thienodiazepine. Diazepin-Referenzverbindung mit ausgeprägtem Risiko synergistischer Atemdepression in Kombination mit Opioiden, Alkohol oder anderen Sedativa. Beim Umgang im Labor sind geeignete persönliche Schutzausrüstung und das Sicherheitsdatenblatt (SDB) zu beachten.

Quellen

Analytischer Verwendungszweck und Laborhinweis

Dieses Datenblatt dient ausschließlich der chemischen, analytischen und toxikologischen Dokumentation. Das Material ist nicht für den menschlichen Verzehr bestimmt. Ein Forschungshinweis begründet keinen Rechtsstatus.

Quellen